BAUSCH + LOMB CORPORATION Financials Bausch + Lomb Corporation
Equities
BLCO
CA0717051076
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.81 USD | -0.60% |
|
+7.79% | -13.19% |
| May. 06 | Bausch + Lomb Shares Rise After Morgan Stanley Upgrade | MT |
| May. 06 | Morgan Stanley Upgrades Bausch + Lomb to Overweight From Equalweight, Raises Price Target to $18 From $16 | MT |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 5,429 | 5,986 | 5,236 | - | - |
| Enterprise Value (EV) 1 | 7,511 | 10,217 | 9,353 | 9,040 | 8,716 |
| P/E ratio | 776 x | -23.1 x | -25 x | -110 x | 40 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 1.44 x | 1.44 x | 1.12 x | 1.06 x | 1.01 x |
| EV / Revenue | 1.99 x | 2.46 x | 2.01 x | 1.83 x | 1.68 x |
| EV / EBITDA | 10.4 x | 13.8 x | 10.8 x | 9.36 x | 7.96 x |
| EV / FCF | 44.2 x | -51.6 x | 30.2 x | 17.7 x | 11.2 x |
| FCF Yield | 2.26% | -1.94% | 3.31% | 5.66% | 8.9% |
| Price to Book | 0.77 x | 0.87 x | 0.76 x | 0.73 x | - |
| Nbr of stocks (in thousands) | 350,001 | 350,881 | 351,402 | - | - |
| Reference price 2 | 15.51 | 17.06 | 14.81 | 14.81 | 14.81 |
| Announcement Date | 2/22/23 | 2/21/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | 3,765 | 3,768 | 4,146 | 4,658 | 4,944 | 5,199 |
| EBITDA 1 | - | 720 | 738 | 865 | 966.3 | 1,095 |
| EBIT 1 | - | 585 | 596 | 647.5 | 730.6 | 832.3 |
| Operating Margin | - | 15.53% | 14.38% | 13.9% | 14.78% | 16.01% |
| Earnings before Tax (EBT) 1 | - | 73 | -166 | -170.7 | -205 | 157 |
| Net income 1 | 182 | 6 | -260 | -236 | -61.57 | 129.3 |
| Net margin | 4.83% | 0.16% | -6.27% | -5.07% | -1.25% | 2.49% |
| EPS 2 | - | 0.0200 | -0.7400 | -0.5920 | -0.1350 | 0.3700 |
| Free Cash Flow 1 | - | 170 | -198 | 310 | 512 | 776 |
| FCF margin | - | 4.51% | -4.78% | 6.66% | 10.36% | 14.92% |
| FCF Conversion (EBITDA) | - | 23.61% | - | 35.84% | 52.99% | 70.85% |
| FCF Conversion (Net income) | - | 2,833.33% | - | - | - | 600.15% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Announcement Date | 3/31/22 | 2/22/23 | 2/21/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 889 | 941 | 942 | 996 | 931 | 1,035 | 1,007 | 1,173 | 1,099 | 1,168 | 1,148 | 1,242 | 1,155 |
| EBITDA 1 | 170 | 182 | 187 | 181 | 141 | 179 | 187 | 231 | 180 | 203.5 | 218.5 | 262.5 | 215.4 |
| EBIT 1 | 140 | 148 | 153 | 144 | 107 | 104 | 152 | 195 | 144 | 150.4 | 163.1 | 206.9 | 153.4 |
| Operating Margin | 15.75% | 15.73% | 16.24% | 14.46% | 11.49% | 10.05% | 15.09% | 16.62% | 13.1% | 12.88% | 14.21% | 16.66% | 13.28% |
| Earnings before Tax (EBT) 1 | 29 | 27 | 19 | -2 | -55 | -19 | -35 | -57 | -90 | -42.5 | -34.5 | -1.5 | - |
| Net income 1 | 20 | 5 | -18 | -1 | -90 | -32 | -84 | -54 | -167 | -41.77 | -32.7 | -0.6 | - |
| Net margin | 2.25% | 0.53% | -1.91% | -0.1% | -9.67% | -3.09% | -8.34% | -4.6% | -15.2% | -3.58% | -2.85% | -0.05% | - |
| EPS 2 | 0.0600 | 0.0100 | -0.0500 | - | -0.2600 | -0.0900 | -0.2400 | -0.1500 | -0.4800 | -0.1150 | -0.0850 | 0.005000 | -0.0300 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 6/8/22 | 8/4/22 | 11/2/22 | 2/22/23 | 5/3/23 | 8/2/23 | 11/1/23 | 2/21/24 | 5/1/24 | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 2,082 | 4,231 | 4,117 | 3,804 | 3,480 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 2.892 x | 5.733 x | 4.76 x | 3.937 x | 3.178 x |
| Free Cash Flow 1 | - | 170 | -198 | 310 | 512 | 776 |
| ROE (net income / shareholders' equity) | - | 4.58% | 3.72% | 3.08% | 4.87% | 7.05% |
| ROA (Net income/ Total Assets) | - | 3.41% | 2.1% | 1.68% | 2.32% | 2.91% |
| Assets 1 | - | 175.7 | -12,388 | -14,086 | -2,653 | 4,438 |
| Book Value Per Share 2 | - | 20.10 | 19.50 | 19.40 | 20.30 | - |
| Cash Flow per Share 2 | - | 0.9900 | -0.0500 | 0.7500 | 1.190 | - |
| Capex 1 | - | 175 | 181 | 252 | 245 | 252 |
| Capex / Sales | - | 4.64% | 4.37% | 5.41% | 4.95% | 4.84% |
| Announcement Date | 3/31/22 | 2/22/23 | 2/21/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
14.9
USD
Average target price
18.71
USD
Spread / Average Target
+25.60%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -13.19% | 5.24B | |
| -4.66% | 185B | |
| -1.01% | 109B | |
| -4.20% | 68.54B | |
| +2.68% | 51.74B | |
| +9.12% | 45.22B | |
| +3.12% | 41.74B | |
| +4.13% | 26.83B | |
| +3.31% | 26.69B | |
| +11.62% | 25.63B |
- Stock Market
- Equities
- BLCO Stock
- Financials Bausch + Lomb Corporation